380 related articles for article (PubMed ID: 10742110)
1. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development.
Saxton TM; Ciruna BG; Holmyard D; Kulkarni S; Harpal K; Rossant J; Pawson T
Nat Genet; 2000 Apr; 24(4):420-3. PubMed ID: 10742110
[TBL] [Abstract][Full Text] [Related]
2. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.
Saxton TM; Henkemeyer M; Gasca S; Shen R; Rossi DJ; Shalaby F; Feng GS; Pawson T
EMBO J; 1997 May; 16(9):2352-64. PubMed ID: 9171349
[TBL] [Abstract][Full Text] [Related]
3. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
4. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract][Full Text] [Related]
5. Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2.
Saxton TM; Pawson T
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3790-5. PubMed ID: 10097116
[TBL] [Abstract][Full Text] [Related]
6. Manifestation of the limb prepattern: limb development in the absence of sonic hedgehog function.
Chiang C; Litingtung Y; Harris MP; Simandl BK; Li Y; Beachy PA; Fallon JF
Dev Biol; 2001 Aug; 236(2):421-35. PubMed ID: 11476582
[TBL] [Abstract][Full Text] [Related]
7. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
8. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
[TBL] [Abstract][Full Text] [Related]
9. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.
Ong SH; Guy GR; Hadari YR; Laks S; Gotoh N; Schlessinger J; Lax I
Mol Cell Biol; 2000 Feb; 20(3):979-89. PubMed ID: 10629055
[TBL] [Abstract][Full Text] [Related]
10. Identification of phosphorylated proteins associated with the fibroblast growth factor receptor type I during early Xenopus development.
Ryan PJ; Paterno GD; Gillespie LL
Biochem Biophys Res Commun; 1998 Mar; 244(3):763-7. PubMed ID: 9535739
[TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility to ischemia-induced brain damage in transgenic mice overexpressing a dominant negative form of SHP2.
Aoki Y; Huang Z; Thomas SS; Bhide PG; Huang I; Moskowitz MA; Reeves SA
FASEB J; 2000 Oct; 14(13):1965-73. PubMed ID: 11023980
[TBL] [Abstract][Full Text] [Related]
12. A novel function for the protein tyrosine phosphatase Shp2 during lung branching morphogenesis.
Tefft D; De Langhe SP; Del Moral PM; Sala F; Shi W; Bellusci S; Warburton D
Dev Biol; 2005 Jun; 282(2):422-31. PubMed ID: 15950607
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1.
Dong Q; Siminovitch KA; Fialkow L; Fukushima T; Downey GP
J Immunol; 1999 Mar; 162(6):3220-30. PubMed ID: 10092773
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase signalling pathways.
Pawson T
Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
[TBL] [Abstract][Full Text] [Related]
16. SHP2 associates directly with tyrosine phosphorylated p90 (SNT) protein in FGF-stimulated cells.
Ong SH; Lim YP; Low BC; Guy GR
Biochem Biophys Res Commun; 1997 Sep; 238(1):261-6. PubMed ID: 9299490
[TBL] [Abstract][Full Text] [Related]
17. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
[TBL] [Abstract][Full Text] [Related]
18. Beta4 integrin activates a Shp2-Src signaling pathway that sustains HGF-induced anchorage-independent growth.
Bertotti A; Comoglio PM; Trusolino L
J Cell Biol; 2006 Dec; 175(6):993-1003. PubMed ID: 17158954
[TBL] [Abstract][Full Text] [Related]
19. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
20. Regulation of neuregulin-mediated acetylcholine receptor synthesis by protein tyrosine phosphatase SHP2.
Tanowitz M; Si J; Yu DH; Feng GS; Mei L
J Neurosci; 1999 Nov; 19(21):9426-35. PubMed ID: 10531446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
